Traws Pharma, Inc. Files 8-K
Ticker: TRAW · Form: 8-K · Filed: Feb 18, 2025 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Feb 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: name-change, corporate-filing
TL;DR
Traws Pharma (fka Onconova) filed an 8-K, likely a name change.
AI Summary
On February 18, 2025, Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) filed an 8-K report. The filing indicates a change in the company's name and potentially other events, though specific details regarding new business activities or financial transactions are not elaborated in the provided text.
Why It Matters
This filing signals a corporate name change for Traws Pharma, Inc., which was formerly known as Onconova Therapeutics, Inc., indicating a potential rebranding or strategic shift.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting a name change, with no immediate indication of significant financial or operational risks.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Onconova Therapeutics, Inc. (company) — Former company name
- February 18, 2025 (date) — Date of report
- 12 Penns Trail Newtown, PA 18940 (address) — Registrant's principal business address
- 267-759-3680 (phone_number) — Registrant's principal business phone number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is February 18, 2025.
What was Traws Pharma, Inc. formerly known as?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
In which state was Traws Pharma, Inc. incorporated?
Traws Pharma, Inc. was incorporated in Delaware.
What is the SEC file number for Traws Pharma, Inc.?
The SEC file number for Traws Pharma, Inc. is 001-36020.
What is the principal business address of Traws Pharma, Inc.?
The principal business address is 12 Penns Trail, Newtown, PA 18940.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding Traws Pharma, Inc. (TRAW).